EFSA reveals several areas of concern in novel food applications
The European Food Safety Authority (EFSA) has found several key areas of concern in novel food submissions it has received for CBD. Among the areas of primary concern are missing information on applications and data gaps, which would support the evaluation of safety profiles, according to information shared during an EFSA-led webinar on 29 June. […]
Beyond the CBD list: Frequently asked questions.
The Food Standards Agency (FSA) published a list of permitted CBD products, and their manufacturers, on 31 March 2022. The emergence of the long awaited list has presented more questions to answer. We asked Laura Williamson, Technical Advisor to the Association for the Cannabinoid Industry, to clear up some of the biggest issues. What led […]
List of CBD products: 100% of ACI consortium applications appear on the FSA’s list
The UK has become the first country in the world to regulate the market for safe, orally consumed legal cannabis extracts, following the release today of the Food Standards Agency’s public list of CBD products permitted for sale to consumers. Among the 70 applicants who have successfully made the list are 45 members of the […]
The UK’s CBD list is here. What happens next?
The long awaited list of ingestible CBD products permitted for sale was published on 31 March 2022. A total of 3,536 products linked to 70 applications have been given the green light to remain on the market by the Food Standards Agency, however the majority are awaiting the outcome of further evidence. This means making […]
FSA update: Rebranding, new products and novel food applications. What does the future hold for white labelled CBD?
The Food Standards Agency (FSA) has doubled down on its novel foods guidance for white labelled CBD oils, edibles and beverages. They say no brands launched after 13 February 2020 are permitted to enter the UK market without full novel foods authorisation. The FSA, which is responsible for protecting public health in relation to food […]
FSA issues clarification and new deadline for toxicology data
A number of CBD companies have until 28 February to provide sufficient toxicology data to the Food Standards Agency, or risk losing the right to sell their products. Cannabinoid Insight has learnt that up to 40 CBD companies which submitted summary data on epilepsy drug Epidiolex in their novel foods application, have until 28 February […]
